Supplemental Figure 1: Multiple adult-onset xanthogranuloma harboring KRAS G12D: a specific activating mutation with potential prognostic and treatment implications

Supplemental figure 1 shows the downstream effects of the activating KRAS G12D mutation on the Mitogen Associated Protein Kinase and mechanistic Target of Rapamycin signaling pathways, as well as the mechanism of KRAS G12D inhibitors.